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Introduction: Prenatal maternal distress has a negative impact on the course of 
pregnancy, fetal development, offspring development and later psychopathologies. The 
study aimed to determine the extent to which the Coronavirus disease 2019 (COVID-19) 
pandemic may aggravate pregnant women prenatal distress and psychiatric 
symptomatology. 
Material and methods: Two cohorts of pregnant volunteer women were evaluated, one 
that was recruited before the COVID-19 pandemic (n=496) through advertisements in 
prenatal clinics in Quebec, Canada, from April 2018 to March 2020; the other (n=1258) 
was recruited online during the pandemic from April 2 to April 13 2020. Prenatal distress 
and psychiatric symptomatology were measured with the Kessler Distress Scale (K10), 
Post-traumatic Checklist for DSM-5 (PCL-5), Dissociative Experiences Scale (DES-II) 
and Positive and Negative Affect Schedule (PANAS).  
Results: The 1754 pregnant women (Mage=29.27, SD=4.23) were between 4 and 41 
gestational weeks (M=24.80, SD=9.42), were generally educated (91.3% had post-high 
school training) and financially well-resourced (85.3% were above the low-income cut-
off). A multivariate analysis of covariance controlling for age, gestational age, household 
income, education and lifetime psychiatric disorders showed a large effect size in the 
difference between the two cohorts on psychiatric symptoms (Wilks’ λ=0.68, 
F6,1400=108.50, p < 0.001, partial η2= 0.32). According to post-hoc analyses of 
covariance, the COVID-19 women reported higher levels of depressive and anxiety 
symptoms (ES=0.57), dissociative symptoms (ES=0.22 and 0.25), symptoms of post-
traumatic stress disorder (ES=0.19), negative affectivity (ES = 0.96) and less positive 
affectivity (ES=0.95) than the pre-COVID-19 cohort. Women from the COVID-19 cohort 
were more likely than pre-COVID-19 women to present clinically significant levels of 
depressive and anxiety symptoms [OR=1.94, χ2(1)=10.05, p=.002]. Multiple regression 
analyses indicated that COVID-19 pregnant women having a previous psychiatric 
diagnosis or low income would be more prone to elevated distress and psychiatric 
symptoms.  
Conclusions: Pregnant women assessed during the COVID-19 pandemic reported more 
distress and psychiatric symptoms than pregnant women assessed before the pandemic, 
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mainly in the form of depression and anxiety symptoms. Given the harmful consequences 
of prenatal distress on mothers and offspring, the presently observed upsurge of 
symptoms in pregnant women calls for special means of clinical surveillance. 
 
Keywords: COVID-19, anxiety, depression, PTSD, mental health, prenatal, pregnancy, 
mothers 
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Key message: The COVID-19 pandemic is associated with an uptrend in psychological 
distress and psychiatric symptomatology in pregnant women. This may have a negative 





There is robust evidence that prenatal psychological distress is harmful to the 
mother, the fetus and eventually the child. Indeed, maternal stress during pregnancy has 
been associated with serious negative outcomes including poor maternal psychosocial 
functioning,1 parenting difficulties,1 lower infant birth weight,2 earlier infant gestational 
age,2 offspring psychopathology,3 alterations in brain development,4 and poorer 
socioemotional5 and cognitive development.6 The detrimental effects of prenatal maternal 
psychological distress would not be limited to the most vulnerable populations since 
higher levels of anxiety and depression during pregnancy would be linked to alterations 
in fetal and infant brain development even in women with low-risk pregnancies, high 
levels of education and high socioeconomic status.4, 7  
While maternal prenatal psychological distress is common in community samples 
of pregnant women,4 major stressors such as health crises and natural disasters would 
increase prenatal stress and exert long-lasting effects on child development.8 Coronavirus 
disease 2019 (COVID-19) has affected everyone around the world while often disrupting 
medical practices in non COVID-19 cases and specifically in prenatal care.9, 10  
Understandably, perinatal research on COVID-19 has primarily focused on 
maternal and neonatal outcomes of COVID-19 infection during pregnancy. The impact of 
the COVID-19 pandemic on mental health in pregnant women remains unknown.10 
Similarly, though medical associations worldwide had to provide clinical guidelines on 
the clinical management of pregnant women and their newborn during the pandemic, 
recommendations related to maternal mental health were limited by the absence of 
empirical data.10 
The aim of the present study was to provide such data. We evaluated to what 
extent the COVID-19 pandemic provoked an increase of prenatal psychological distress 
in pregnant women, as measured by two domains of symptoms: i) depressive and anxiety 
symptoms (i.e. high prenatal distress, high negative affectivity, low positive affectivity) 
and trauma-related symptoms (i.e. dissociation and symptoms of post-traumatic stress 
disorder). We also assessed whether a particular subgroup of pregnant women would 
express more vulnerability.  
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Material and methods 
Study Design and sample 
A first cohort of pregnant women was recruited into a longitudinal study in 
prenatal clinics before the COVID-19 pandemic, from April 2018 to March 1 2020, 
through an invitation to participate in a research on early life experiences and parenthood. 
A second cohort was recruited during the active COVID-19 pandemic from April 2 to 
April 13 2020 through social media (Facebook and Instagram) and advertisements in 
prenatal clinics. All participants were volunteers from the Province of Quebec, Canada, 
where a public health emergency was declared in reaction to COVID-19 on March 13 
2020. This culminated into the closure of all non-essential businesses, self-isolation and 
restriction of non-essential displacements from March 24 until May 4. The enrolment of 
the COVID-19 pandemic cohort actually took place when the pandemic was well under 
way. Inclusion criteria were being 18 or older, having sufficient reading skills to 
complete self-report instruments and being pregnant at the time of assessment. Measures 
were completed online on a secure portal. Informed consent was obtained from all 
participants.  
Measures 
Two instruments showing strong correlations with anxiety disorders and 
depression and two questionnaires of trauma-related disorders (post-traumatic stress 
disorder and dissociation) were selected for measuring prenatal psychological distress. 
Anxiety and depression were first measured using the 10-item Kessler Psychological 
Distress Scale (K10).11, 12 Higher scores at the K10 indicate more symptoms and distress 
and 76.3% of respondents with scores ≥30 would meet the criteria for a DSM-IV anxiety, 
affective or substance use disorder during a diagnostic interview.13 Both the English and 
French versions have similarly satisfactory psychometric properties11 and the instrument 
has been shown to screen adequately for mood and anxiety disorders in pregnant 
women.14 Cronbach’s alpha for the K-10 in this study was .88. 
Positive and negative affect were assessed using the Positive and Negative Affect 
Schedule (PANAS).15, 16 The Positive Affect scale probes for feelings such as enthusiasm, 
energy and dynamism whereas the Negative Affect scale catches feelings of anger, fear, 
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guilt and nervousness. Scores on the Positive Affect Scale were reversed to reflect low 
positive affectivity. The original and the French version have shown up as valid and 
reliable,16, 17 and PANAS scores were shown to be associated with DSM-IV major 
depressive disorder in pregnant women.18 The Cronbach’s alpha for the Positive affect 
and Negative affect subscales were .85 and .89 respectively. 
The Post-traumatic stress disorder (PTSD) Checklist for DSM-5 (PCL-5) assessed 
post-traumatic stress symptoms during the past month and is based on the PTSD 
diagnostic criteria of the DSM-5.19, 20 Its 20 items can be regrouped into four subscales 
corresponding to the clusters of symptoms of a PTSD diagnosis in the DSM-5: intrusion 
(Cluster B; 5 items), avoidance of trauma-related stimuli (Cluster C; 2 items), negative 
alterations in cognitions and mood (Cluster D; 7 items), and alterations in arousal and 
reactivity (Cluster E; 6 items). Higher scores indicate more severe symptoms (clinical 
cut-off ≥33).20 The instrument was previously used in samples of pregnant women21 and 
both the French and the original versions have equally adequate validity and reliability.19 
The Cronbach’s alpha for the PCL-5 in this study was .92. 
Dissociation was measured with the depersonalization/derealization (6 items) and 
absorption/imaginative involvement (9 items) subscales of the Dissociative Experiences 
Scale (DES-II).22, 23 The instrument was previously used in samples of pregnant women24 
and has good validity and reliability.22, 23 The Cronbach’s alpha for the DES in this study 
was of .75 for the depersonalization subscale and .83 for the absorption subscale. 
A sociodemographic questionnaire was administered to assess potentially 
confounding variables, including age, gestational age, education, annual income and 
history of psychiatric disorders. For the latter, participants had to confirm all mental 
health disorders among the following for which they received a medical diagnosis at one 
point in their life: major depressive disorder, anxiety disorder, PTSD, eating disorder, 
bipolar disorder, psychotic disorder, personality disorder, ADHD, or other disorder 
(Table 1). 
Statistical analysis 
Analyses were performed with SPSS, version 24.0. The characteristics of the 
participants across the two cohorts were compared using t-test for continuous variables 
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and chi-squared test for categorical variables. To meet our first objective, we performed a 
multivariate analysis of covariance (MANCOVA) to evaluate whether the pre-COVID-19 
and COVID-19 pandemic cohorts differed on the six symptoms. Subsequent ANCOVAs 
were performed to examine group differences on the six symptoms separately. Scores 
were converted to z scores. All analyses controlled for age, gestational age, education 
level, household income and lifetime psychiatric disorders. We calculated effect sizes 
(ES) using the difference of adjusted means between the COVID-19 and the pre-COVID-
19 cohorts divided by a pooled standard deviation. In complement to analyses on 
continuous variables, we wanted to compare the two cohorts using categorical analyses 
via established cut-offs for the K10 and PCL-5 and used chi-squared tests to test 
homogeneity.  
To meet our second objective, i.e. identifying a subgroup potentially more 
vulnerable to prenatal distress during the pandemic, we first conducted in the COVID-19 
cohort a factor analysis with Varimax rotation on the six symptoms, in order to diminish 
the number of meaningful symptoms to be analyzed (see Results and Table S4). A strong 
factorial structure was obtained. We then performed multiple regressions with the 
COVID-19 women’s characteristics as predictors and their factor score on each of the 
three factors. Given that three regression analyses were performed, we conservatively 
applied Bonferroni corrections and the significance level was fixed at p < .02. 
Ethical approval 
This study was approved by the Institutional Review Board of Université du 
Québec à Trois-Rivières (#CER-20-266-10.10) on April 2 2020. 
Results 
The sample consisted of 1754 pregnant women, ranging from 18 to 46 years old 
(M=29.27, SD=4.23). The characteristics of the two cohorts are presented in Table 1. 
Among the participants, 91.3% had post-high school training and 85.3% were above the 
low-income cut-off of 33 863CND for a family with two children. The median household 
income in our sample was between 85 000 and 95 000CND. Our sample of pregnant 
women would thus be highly representative of Quebec’s population of mothers since 
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91,5% of women between 25 and 34 have post-high-school education and the median 
income for a household of two people or more is of 87 400CND in Quebec. The majority 
of the sample was Caucasian (95%). The pre-COVID-19 and COVID-19 cohorts had 
similar age and lifetime diagnoses of psychiatric disorders, but the COVID-19 cohort was 
significantly more educated, had higher household income and had slightly older 
gestational age (Table 1). Of the 1754 participants, 342 had missing data on at least one 
instrument (Table S1). No demographic difference was found between participants with 
complete data and those with missing data (Table S2). Moreover, the analyses including 
only participants with complete data (n=1412; Table S3) yielded the same results as the 
analyses in the total sample (n=1754) shown below. 
Pregnant women from the COVID-19 pandemic cohort reported more prenatal 
distress than pregnant women from the pre-COVID-19 cohort (MANCOVA; Wilks’ 
λ=0.68, F6,1400=108.50, p < 0.001, partial η2= 0.32) even when controlling for the effect 
of age (Wilks’ λ=0.98, F6,1400=4.13, p < 0.001, partial η2= 0.02), gestational age (Wilks’ 
λ=0.99, F6,1400=1.26, p=0.28), education (Wilks’ λ=0.98, F6,1400 = 5.16, p < 0.001, partial 
η2= 0.02), household income (Wilks’ λ=0.97, F6,1400=8.42, p < 0.001, partial η2= 0.04) 
and lifetime psychiatric diagnoses (Wilks’ λ=0.92, F6,1400=21.16, p < 0.001, partial η2= 
0.08). Post hoc ANCOVAs (Table 2) revealed more severe symptoms of depression and 
anxiety, higher levels of negative affectivity and lower levels of positive affectivity in the 
COVID-19 cohort. Pregnant women assessed during the pandemic also reported more 
symptoms of PTSD and dissociation than women from the pre-COVID-19 cohort. Since 
a diagnosis of PTSD requires the combination of four types of symptoms (see Methods), 
we next analyzed PTSD clusters of symptoms separately. We observed that the COVID-
19 cohort reported more alterations in cognitions and mood (criterion D of a PTSD 
diagnosis; F1,1563=28.50, p < 0.001, ES=.29) and alterations in arousal and reactivity 
(criterion E; F1,1562=20.83, p < 0.001, ES=0.24) but had similar levels of intrusion and 
avoidance than the pre-COVID-19 cohort.  
We then performed categorical analyses of symptoms dividing participants into 
low/moderate vs high risk of having a DSM disorder based on previously validated K10 
clinical cut-off (K10 scores ≥ 30).13 Results showed that 10.9% of the COVID-19 cohort 
10 
 
had clinically significant symptoms of anxiety and depression in comparison to only 
6.0% of the pre-COVID-19 cohort [OR=1.94, χ2(1)=10.05, p=.002]. However, the two 
cohorts were similar in PTSD symptoms [χ2(1)=1.77, p=.18]. 
The factor analysis of the 6 psychiatric symptoms yielded in the COVID-19 
cohort a strong three factors structure explaining respectively 49%, 18% and 14% of the 
total variance: Factor 1 was composed of mood and anxiety symptoms 
(anxiety/depression; negative affectivity; PTSD), Factor 2 of dissociative symptoms and 
Factor 3 of low positive affectivity (see Table S4). Multiple regression analyses having 
each a Factor as the predicted variable (Table 3) showed that lifetime psychiatric 
disorders and household income were the best predictors of Factor 1 mood and anxiety, 
and of Factor 2 dissociative symptoms. Factor 3 low positive affectivity was predicted by 
lifetime psychiatric disorders, education levels and gestational age. 
Discussion 
To the best of our knowledge, this is the first study reporting a significant surge of 
distress and psychiatric symptoms in pregnant women during the COVID-19 pandemic.10 
We contrasted two large cohorts of pregnant women from the general population, one 
assessed before and the other during the COVID-19 pandemic, by using the same 
measurements. The public health and mental health relevance of our study is markedly 
supported by the documented negative impact of psychological distress during pregnancy 
on both mothers’ and offspring’s health.1, 3-5  
Our study indeed revealed differences with small to large effect sizes between the 
pre-COVID-19 and the COVID-19 cohorts on all psychiatric symptoms. More 
specifically, during the pandemic, pregnant women would mainly exhibit an upsurge of 
depressive and anxiety symptoms (defined as high psychological distress, high negative 
affectivity and low positive affectivity) along with some symptoms of dissociation and 
post-traumatic stress disorder. However, post-hoc analyses revealed that only the clusters 
of PTSD symptoms overlapping with anxiety and depression (i.e. negative mood and 
cognitions; alterations in reactivity and arousal), and not symptoms that are more specific 
to PTSD (i.e. intrusion symptoms and avoidance of trauma-related stimuli), increased 
during the COVID-19 pandemic. Remarkably, also, a history of a psychiatric disorder 
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prior to the pandemic, younger age, lower household income and lower education were 
all associated with higher maternal psychological distress. It is noteworthy that the 
differences in symptomatology between the two cohorts remained significant after 
controlling for the above variables. This finding adds to previous results suggesting that 
high levels of prenatal distress would not be limited to the most vulnerable subgroups of 
pregnant women.4, 7 
Moreover, our using a categorical validated cut-off on the symptoms scales to 
compare the pregnant women with higher symptomatology to those with minimal or 
lower symptomatology yielded congruent results on changes in psychiatric clinical status. 
The COVID-19 pregnant women would show up as almost twice more likely to present a 
level of symptoms meeting a DSM diagnosis of affective, anxiety or substance use 
disorder, but showed no risk difference for a DSM diagnosis of PTSD which was 
somewhat congruent with the previous results from the continuous analysis on PTSD 
clusters of symptoms.  
Our findings have clinical meaning for primary and specialized care. Indeed, 
easily measurable attributes in the clinic, such as a personal history of psychiatric 
disorder and lower sociodemographic status, would predict higher psychiatric 
symptomatology in the pandemic and thus definitely higher health risk for the mother and 
child.1-7 As detailed below in the conclusion, our data advocate for special forms of 
clinical surveillance of pregnant women who exhibit these characteristics, as well as 
targeted information in primary care facilities and from public informants.  
Our findings have also implications for developmental psychopathology. Prenatal 
psychological distress has been repetitively shown to be associated with poor 
developmental outcomes in offspring such as alterations in brain development4, 7 and 
poorer socioemotional and cognitive development.5, 6 In that respect, it may be relevant to 
attempt a comparison of our present findings with previous studies from the same 
population. For instance, previous Quebec studies have shown that prenatal maternal 
distress resulting from another stressful event at the population level (the 1998 Quebec 
Ice Storm; see SDiscussion in the Supplement) had an effect on offspring DNA 
methylation,25 metabolic pathways involved in energy metabolism and protein 
biosynthesis,26 cognitive and linguistic functioning,27 and motor fonctions.28 The current 
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COVID-19 pandemic may be considered at least as stressful as the Quebec Ice Storm and 
the high rates of maternal prenatal psychological distress we reported in the current study 
suggest that similar developmental outcomes will be observed in a substantial proportion 
of offspring born to women that were pregnant during the COVID-19 pandemic. 
The implications for future studies are several. Our data call for biological studies 
including environmental, epigenetic and risk mechanisms at play in the short- and long-
term consequences of prenatal psychological distress on offspring development.1-7 In this 
respect, future clinical research is needed to assess more thoroughly the effects of the 
COVID-19 pandemic on the maternal psychiatric status and offspring developmental 
trajectory, notwithstanding of course the outcome studies of psychosocial and 
pharmacological interventions in prenatal or postnatal period targeting the child and 
family, which is often neglected to the benefit of correlational research.29 
Our study presents limitations and strengths to be considered when interpreting 
the findings. One strength was certainly the investigation, using the same extensive array 
of measurements, of two large and very similar cohorts of pregnant women from the 
same population, one that was assessed prior to the pandemic and the other during. A first 
limitation may be the difference in recruitment methods between the two cohorts, the 
COVID-19 cohort consisting of volunteers recruited online mainly through social media, 
while the pre-COVID-19 cohort was recruited in prenatal clinics. For instance, our 
education levels and socio-economic data suggest a more privileged sample in the 
COVID-19 pandemic cohort. In contrast, the two cohorts were similar in lifetime 
psychiatric diagnoses and age. Moreover, all comparison analyses did control for age, 
education level, household income, gestational age, and prior psychiatric disorder, then 
minimizing potential analytic biases. A second limitation of studies like this one is the 
impossibility of comparing the respondents to the non-respondents at enrollment, which 
may limit the generalizability of results. However, the level of education and the median 
household income of the participants were the same as those of women from Quebec’s 
population. A third limitation in the study of such large samples is that measurements 




In sum, pregnant women would be particularly likely to experience high levels of 
depression and anxiety symptoms during the COVID-19 pandemic, which may have a 
deleterious impact on mothers and fetuses even in socioeconomically privileged women 
with low-risk pregnancies.1, 4, 7 The present findings would call for the rapid 
implementation of clinical and public health strategies targeting particularly pregnant 
women with a history of psychiatric disorder and modest income. As recently advocated 
regarding the mental health impact from the COVID-19 pandemic,30 our findings may 
inform medical academies and decision makers i) in their recommendations to 
practitioners, particularly in mental health surveillance of pregnant women during the 
COVID-19 pandemic, such as simply inquiring about specific distress or symptoms 
during prenatal cares, or inquiring about the level of paternal support, ii) in their support 
of different forms of telehealth assistance to women with elevated psychological distress, 
such as toll-free helplines to answer pregnant women questions and online psychological 
support, iii) to encourage public health organizations to disseminate information about 
distress and relief of distress in pregnant women. Ideally, our findings would support a 
global approach of the family given that both the distressed mother and child would be in 
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Table 1. Clinical and demographic characteristics of pregnant women from the COVID-19 and pre-COVID-19 cohorts. 
Variables Characteristics 
COVID-19  
(n = 1258) 
N (%) 
Pre COVID-19 






Any lifetime diagnosis 250 (19.9) 105 (21.2) χ2(1) = 0.37, p = .54 
Major depressive disorder 30 (2.38) 20 (4.03)  
Anxiety disorder 159 (12.64) 64 (12.90)  
Bipolar disorder 6 (0.48) 4 (0.81)  
Eating disorder 6 (0.48) 5 (1.01)  
Psychotic disorder 0 (0.00) 1 (0.20)  
Personality disorder 22 (2.75) 14 (2.82)  
PTSD 15 (1.19) 8 (1.61)  
ADHD/ADD 87 (6.92) 39 (7.86)  
Others 7 (0.56) 3 (0.60)  
Household 
income (CND) 
< 35 000$ 87 (6.90) 74 (15.90) 
χ2(3) = 58.94, p < .001 35 000$–64 999$ 197 (15.70) 115 (23.20) 65 000$–94 999$ 403 (32.00) 162 (32.70) 
≥ 95 000$ 571 (45.40) 145 (29.20) 
Education High school not completed  13 (1.00) 26 (5.20) χ2(4) = 67.33, p < .001 
High school diploma 74 (5.90) 39 (7.90) 
 Collegial/professional 490 (39.00) 252 (50.80) Undergraduate degree 401 (31.90) 115 (23.20) 
Graduate degree 280 (22.30) 64 (12.90) 
 Mean (SD) Mean (SD)  
Maternal age (years) 29.35 (4.04) 29.07 (4.65) t’(807.36) = -1.22, p = .22 
Gestational age (weeks) 24.38 (9.26) 25.85 (9.73) t’(867.92) = 2.88, p = .004 
a Participants reported on all medical diagnoses they received according to a list of 8 diagnoses 
Abbreviations. PTSD, Post-traumatic stress disorder; ADHD/ADD, Attention-deficit hyperactivity disorder / Attention deficit disorder. 
CND, Canadian dollar.  
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Table 2. Analyses of covariance comparing the pre-Covid-19 cohort to the COVID-19 cohort of 
pregnant women on six psychiatric symptoms. 
ANCOVAs were performed to examine group differences on the psychiatric symptoms separately. 
Scores were previously converted to z scores. The analyses controlled for age, gestational age, 
education level, household income and lifetime psychiatric disorders. Effect sizes (ES) were calculated 
using the difference of adjusted means between participants of the COVID-19 and pre-COVID-19 
cohorts divided by a pooled standard deviation.  
Abbreviations. M, Estimated marginal means; SE, Standard error; df, degree of freedom; P, probability 
value; ES, Effect sizes.  




(n = 1741) 
Pre-COVID-19 -0.39 0.04 
1, 1734 112.93 < .001 0.57 
COVID-19 0.15 0.03 
Negative affectivity 
(n = 1730) 
Pre-COVID-19 -0.64 0.04 
1, 1723 321.80 < .001 0.96 
COVID-19 0.25 0.03 
Low positive affectivity 
(n = 1730) 
Pre-COVID-19 -0.64 0.04 
1, 1723 316.96 < .001 0.95 
COVID-19 0.25 0.03 
Post-traumatic stress 
(n = 1568) 
Pre-COVID-19 -0.12 0.04 
1, 1561 11.40 .001 0.19 
COVID-19 0.06 0.03 
Dissociation 
Absorption  
(n = 1468) 
Pre-COVID-19 -0.15 0.04 
1,1461 16.32 < .001 0.22 
COVID-19 0.07 0.03 
Dissociation/ 
Depersonalization  
(n = 1462) 
Pre-COVID-19 -0.17 0.05 
1, 1455 19.71 < .001 0.25 
COVID-19 0.08 0.03 
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Table 3.  Multiple regressions assessing the association between sociodemographic characteristics and the three clusters of 
symptoms in pregnant women of the COVID-19 cohort. 
Criteria Predictors Adjusted R2 B SE β P-value 
95% CI  
lower 
bound 






Lifetime psychiatric disorder 
0.07 
0.52 0.07 0.21 < .001  0.39 0.64 
Age -0.01 0.006 -0.03 .24 -0.02 0.01 
Education -0.08 0.03 -0.07 .02 -0.14 -0.02 
Household income -0.03 0.01 -0.08 .005 -0.06 -0.01 
Gestational age 0.001 0.003 0.009 .72 -0.004 0.01 
Dissociative 
symptoms 
Lifetime psychiatric disorder 
0.06 
0.34 0.07 0.14 < .001 0.21 0.47 
Age -0.001 0.007 -0.01 .85 -0.01 0.01 
Education -0.07 0.03 -0.07 .03 -0.13 -0.006 
Household income -0.06 0.01 -0.14 < .001 -0.08 -0.03 
Gestational age 0.00 0.003 0.001 .96 -0.01 0.01 
Low positive 
affectivity  
Lifetime psychiatric disorder 
0.03 
0.20 0.07 0.08  .003 0.07 0.33 
Age -0.08 0.007 -0.03 .22 -0.02 0.01 
Education 0.12 0.03 0.12 < .001 0.06 0.19 
Household income 0.02 0.01 0.05 0.14 -0.01 0.04 
Gestational age -0.01 0.003 -0.09 < .001 -0.02 -0.004 
A factor analysis was performed on the COVID-19 cohort to regroup the six clinical symptoms into a limited number of meaningful 
clusters. The analysis yielded three domains of symptoms: mood and anxiety symptoms (including symptoms of anxiety/depression, 
negative affectivity and symptoms of PTSD), dissociative symptoms and low positive affectivity (see Table S4). Three multiple 
regressions were next performed with the COVID-19 women’s clinical and sociodemographic characteristics as predictors and the 
factor scores as criteria. The significance level was fixed at p < .02.  
Abbreviations. B, understandardized beta; β, standardized beta; SE, Standard error for the understandardized beta; P, probability 
value; CI, confidence intervals.  
 
 
